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Abstract  
 
Background: Tea is the second most addictive worldwide after formulations containing caffeine in carbonated beverage. Green tea is 
made from leaves of the Camellia sinensis plant. In the repertoire of traditional Chinese medicine, green tea beverages have played a 
fundamental role associated with their culture. It has been suggested that green tea has a number of positive health benefits that are 
reviewed and discussed in this minireview. 
Materials and Methods: We performed a search using the key words “green tea” AND “antiviral” covering the last 10 years. The 
consulted data based were PubMed, ISI Web of Knowledge, Scopus, Reuters and Thomson.  
Results: The results of the searching greatly support that green tea presents both antibacterial and antiviral effects. The beneficial effects 
of green tea are mainly attributed to the presence of a type of polyphenols known as catechins and formed by several isomers including  
(-) - epigallocatechin gallate (EGCG),  (-) - epigallocatechin, (-) - epicatechin gallate, (-) -epicatechin, and (+) - catechin. The catechins in 
green tea have a wide range of antiviral activity against a variety of viruses that act by interfering with its replication cycle.  
Conclusion: A detailed information on the antiviral activity of green tea in a number of different viruses show a promising future as a 
popular drink and also as a potential therapeutic agent. 
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Introduction  
 
Viral infections are among the most common types of infections encountered by mankind. Treating viral infections is limited 
by the availability of drugs. Drugs approved so far have limited applications due to comparatively inferior cure rates, their side effects 
and the rapid accumulation of drug resistant mutants (Piret and Boivin, 2011). The insufficient therapeutic applications of these agents 
including interferon and nucleotide analogs have strengthened the search for alternative antiviral agents for the treatment of viral 
infections (Xu et al. 2008; Jin, 2013; Hameed and Ahmed, 2014). 
Undoubtedly, tea is the most frequently consumed beverage on a global basis, second only to water (Steinmann et al. 2013). 
The customary consumption has long been attributed to various health benefits, including chemo-preventive efficacy and its use has been 
cited as early as in China in 3000 BC or even earlier (Suzuki et al. 2012). Camellia sinensis, used in traditional Chinese medicine, is 
considered to have beneficial properties for human and animal health including cardioprotective, anti-carcinogenetic and anti-infective 
effects (Lee et al. 2002).  
The green tea is a product of the plant Camellia sinensis that is dried and steamed to avoid fermentation (Chacko et al. 2010). 
The flavonoids present in the green tea have two aromatic rings, A and B with hydroxyl groups (Hara, 2011). Most of the health benefits 
of green tea can be attributed to its polyphenols that comprise 25 to 35% in composition. These polyphenolic compounds are also known 
as catechins under the group of flavones, which are a subtype of flavonoids (Meltzer et al. 2009). The major catechin in green tea is (-)-
epigallocatechin gallate (EGCG) (Figure 1), which make up about 59% of the total catechins of green tea leaves. Other catechins in green 
tea are (-)-epigallocatechin (EGC) (19%) (Figure 2), (-)-epicatechin-gallate (ECG) (13.6%) (Figure 3), and (-)-epicatechin (EC) (6.4%) 
(Figure 4) (McKay and Blumberg, 2002; Tran, 2013; Jin, 2013) and (+)-catechin) (Figure 5). 
Green tea polyphenols are best known for their diverse biological and pharmacological activities, including anti-oxidative 
(Song et al. 2005), anti-proliferative (Yang et al. 2002; Conde et al. 2014; Gao et al. 2015) anti-inflammatory, antibacterial (Anita et al. 
2015), antifungal (Yiannakopoulou, 2012), and antiviral activities (Araghizadeh et al. 2013). Evidence shows that green tea is also 
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effective against hypercholesterolemia and hyperglycemia (Yousaf et al. 2014). In this sense, in vitro preparations like isolated aorta have 
made an invaluable contribution to phytopharmacology (Vinet et al. 2012) with important results (Vinet et al. 2014; Fuentes et al. 2015). 
Green tea polyphenols harbors a wide spectrum of activities against different ribonucleic acid (RNA) and deoxyribonucleic 
acid (DNA) viruses (Lin et al. 2013). The antiviral property of polyphenols is due to their antioxidants nature, inhibition of the enzymes 
involved in viral replication and to their cell membrane disruption. The green tea polyphenols also avert viral penetration and binding to 
cells triggering the self-defense of the host cell influencing the activity of a variety of signal transduction pathways (Friedman, 2007). 
EGCG can inhibit the invasion of human umbilical vein endothelial cells (Yamakawa et al. 2004), prevents tumor blood vessel growth 
(Pfeffer et al. 2003), protects human retina cells, ocular neovascularization and vascular permeability (Lee et al. 2014), inhibits 
fibrillogenesis of chicken cystatin (Wang et al. 2015) and offers protection against mutagenesis (Lee et al. 2003). 
The foremost objective of this minireview is to amalgamate, summarize and elucidate the widely divergent information 
available on green tea and its derivative compounds, and their effects on various pathogenic viruses in human and animals. 
 
Antiviral Effects of Green Tea 
Adenovirus  
 
Adenoviruses (Ads) are involved in a variety of human and animal pathologies (Whickam, 2000). Intermittent shedding of Ads 
establishes a persistent asymptomatic infection (Garnett et al. 2002). Adenoviruses infect the lining of the eyes and intestine causing 
conjunctivitis and gastroenteritis respectively. They also colonize on mucous membranes of respiratory and urinary tracts and cause other 
symptoms (Friedman, 2007). Adenoviruses proteases, involved in cancer metastasis, are inhibited by green tea catechins (Weber et al. 
2003). Green tea and, in particular, EGCG inhibit one or more late steps of virus infection against adenovirus and are efficiently taken up 
by the cells (Williams et al. 2000). This sensitivity may be mediated by the inhibition of some cellular processes that depends on viral 
infection. Antiviral properties of EGCG have been demonstrated at various levels, including direct inactivation of the virus particle, 
inhibition of the protease adenain and inhibition of intracellular growth in vitro (Weber et al. 2003). Aslam et al. (2015), report antiviral 
activity of green tea and its isolated catechins against the fowl adenovirus type-4 through in vitro in cell culture and in vivo in broiler 
chickens against IBH-HPS virus challenge. 
 
Hepatitis B Virus 
 
It is estimated that about 40% of the worldwide human population suffers from hepatitis B virus (HBV) (Shepard et al. 2006). 
In Asia, 5% of the population is chronically infected with HBV and infection is considered endemic (Lee, 1997). Catechins have shown 
to be active in several models of inflammatory liver injury and often used in the treatment of human liver diseases such as hepatitis C and 
alcoholic cirrhosis (Gloro et al. 2005). Green tea extract (GTE) reveals a prevailing inhibitory effect on the expression of hepatitis B 
surface antigen (HBs Ag) and hepatitis B e antigen (HBe Ag). Evidence has shown that HBe Ag plays a role in viral persistence. It has 
been suggested that HBe Ag endorse HBV chronicity by acting as an immune-regulatory protein (Chen et al. 2005). Recent results 
demonstrated that GTE had an inhibitory effect on intestinal α-glycosidases that is important for processing glycoproteins and glycolipids 
in viruses (Zhong et al. 2006). EGCG significantly inhibits the replicative intermediates DNA (RI DNA) synthesis, which reduces the 
production of covalent closed circular DNA (He et al. 2011). Pang et al. (2014) demonstrated that EGCG has a strong anti-HBV activity 
through decreasing the secretion of HBs Ag and HBe Ag in vitro. Huang et al. (2014) suggested that new strategies could be used in 
combination with other antiviral drugs to reduce the emergence of resistant viruses. 
 
Hepatitis C Virus  
 
Hepatitis C virus (HCV) infection is a serious health hazard globally. More than 160 million people worldwide are chronically 
infected with HCV (Lavanchy, 2011). Chronic hepatitis caused by HCV infection leads to the higher occurrence of progressive liver 
diseases, including hepatocellular carcinoma, cirrhosis and fibrosis (Lin et al. 2013). However, effective therapies are highly expensive 
and hence these out of reach of most of the patients. These are further burdened with side effects such as anemia appearance and resistant 
variant, which limit the effectiveness of these remedies (Salloum and Tai, 2010). 
EGCG has been shown to inhibit HCV entry into target cells and prevents cell-to-cell spread between adjacent cells (Ciesek et 
al. 2011). In a cell-free system, EGCG also inhibits the major HCV NS3/4A serine protease and NS5B polymerase (Roh and Jo, 2011). It 
was reported that EGCG inhibits the entry of HCV pseudo and cell culture-derived particles independent of HCV genotype (Calland et al. 
2012; Colpitts and Schang, 2014). EGCG also inhibits the replication cycle (Chen et al. 2012). It has been demonstrated that EGCG 
cleared the HCV at 50 µM after three passages in human cells (Calland et al. 2012). In general, green tea gallate catechins are inhibitors 
of hepatitis C virus (Fukazawa et al. 2012). 
 
Influenza Virus 
 
Influenza is one of the most common and severe viral diseases, causing varying degrees of systemic symptoms, such as mild 
fatigue, respiratory failure and even death (Wen et al. 2012). Anti-influenza drugs, M2 channel blockers and sialidase inhibitors (Deyde et 
al. 2009), are effective if administration follows immediately after infection (Carr et al. 2002). Therefore, there is a need to develop new 
antiviral agents for therapeutic uses (Sahaa et al. 2010).  
The survival rate of experimental animals challenged with influenza virus was significantly enhanced when they were 
previously treated with EGCG at 40 mg/kg body weight (Liu et al. 2013). In Madin Durby Canine Kidney (MDCK) cells, EGCG at 20 
nmol/l suppressed the level of reactive oxygen following influenza A infection (Ling et al. 2012). The green tea extract inhibited the 
replication of influenza viruses by preventing acidification of intracellular compartment, such as lysosomes and endosomes (Lee et al. 
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2012; Matsumoto et al. 2012). Hydrolysable tannins obtained from the tea plant inhibited the influenza virus in the early stage of 
infection (Sahaa et al. 2010). It has been demonstrated that consumption of catechins for 5 months produced significant inhibitory effects 
on influenza virus infection, and they were well tolerated (Matsumoto et al. 2012). Yang et al. (2014) compared in vitro antiviral activity 
of various components of green tea in influenza virus A and B. Green tea has been reported to inhibit influenza A virus replication, effect 
mediated by the binding of catechins to the active pocket in the endonuclease domain of the viral RNA-dependent RNA polymerase. 
Since this enzyme is highly conserved among influenza A virus variants, the catechins extract could become an anti endonuclease herbal 
drug (Bustamante and Morales, 2012). 
 
Human Immunodeficiency Virus (HIV) 
 
HIV-1 is the etiological agent of acquired immunodeficiency syndrome (AIDS) belonging to the Lentivirus group of the family 
Retroviridae. HIV infects CD4+ T-lymphocytes, resulting in its depletion and leading to the development of immunodeficiency. EGCG 
acts as an allosteric reverse transcriptase inhibitor of HIV-1 infection decreasing the p24 antigen concentration (Li et al. 2011). EGCG 
inhibits HIV-1 by directly interacting with the D-1 domain of CD4 and the pocket that binds gp120 (Williamson et al. 2006). In the 
presence of EGCG, viral transcription is affected by decreasing the expression of the messenger ribonucleic acid (mRNA) (Yamaguchi et 
al. 2002). EGCG has also shown the ability to inhibit the HIV-1 integrase protein (Jiang et al. 2010). HIV infection leads to severe 
complications affecting the central nervous system (McArthur et al. 2010). EGCG and EC are candidates for the treatment of 
neurological complications of HIV infection due to their simple structure and ability to penetrate the blood-brain barrier (Nath et al. 
2012). 
 
Bovine Coronavirus 
 
Bovine coronavirus (BCV) is the causal pathogen for diarrhea in cattle, which often result in remarkable economic losses 
(Traven et al. 2001). For the treatment of BCV infection in farm animals, green tea polyphenols have a promising future. The antiviral 
activity of EGCG molecules depends on the interaction involving S1 proteins of BCV. EGCG inhibits BCV more efficiently in the 
bovine intestinal tract, where the temperature of approximately 37 °C is appropriate for the antiviral efficacy of EGCG against BCV. 
 
Epstein–Barr virus 
 
Epstein-Barr virus (EBV) is a human herpesvirus that selectively binds to and infects human B-lymphocytes (B-cells), causing 
mononucleosis (Bravender, 2010). EGCG controls the expression of EBV lytic protein including EA-D, Zta and Rta (Chang et al. 2003). 
EGCG directly inhibits the transcription of EBV immediate early gene before EBV-encodes polymerase and causes the arrest of EBV 
lytic cascade. EGCG arrests epidermal growth factor stimulated at the mid G1 phase of breast epithelial cells and prevents cells from 
entering the S phase. EBV immediate-early gene may be regulated by EGCG via cell cycle control (Liberto and Cobrinik, 2005). EGCG 
decreases the phosphorylation and commencement of extracellular signal-regulated kinase 1/2 (ERK1/2), which efficiently restrain the 
constitutive EBV infection at the gene transcription level, and DNA and protein level (Liu et al. 2013). EGCG inhibits the EBV infection 
through the EBV induced B-cell outgrowth and B-lymphocyte transformation (Choi et al. 2009). 
 
Enterovirus 71 
 
Enterovirus 71 (EV71) belongs to the family Picornaviridae, having non-enveloped RNA genome causing outbreaks 
occasionally worldwide (Racaniello, 2001). EGCG and ECG inhibit EV-71 replication and formation of infectious progeny virions. The 
effect of EGCG on EV71 infection is produced by reducing the oxidative stress associated with the infection and by inhibiting the 
enhanced EV-71 replications in G6PD-deficient cells (Ho et al. 2009). It has been proposed that the potent antioxidant activity of EGCG 
and ECG against infections caused by EV 71 is due to the presence of the gallate group and the trihydroxy-B ring having free radical 
scavenging activity. Accordingly, a positive correlation between the antioxidant effects of catechins and their antiviral activities has been 
suggested (Ho et al. 2009).  
 
Herpes Simplex Virus   
 
Herpes simplex virus (HSV) is one of the most widespread human infectious diseases causing genital infection with HSV-2 or 
oral infection with HSV-1 (Oliveira et al. 2013). EGCG operates its antiviral activity through oxidation and dimerization by oxidative 
reactions, which disrupt the HSV envelope (Sang et al. 2005). EGCG is stable at vaginal pH and shows a potential as a candidate for use 
as a topical microbicide to trim down the transmission of HSV. EGCG also potentially interrupt the synergistic association between the 
HSV and HIV infection with direct effects on the virion itself (Isaacs et al. 2008). This interruption results in a reduction of the spread of 
HSV in vivo (Isaacs et al. 2011). Prodelphinidin B-2 3′-O-gallate obscured the HSV-2 reproduction in Vero cell without considerable 
adverse effects on the growth and cell viability (Cheng et al. 2002). EGCG modified with palmitate enhanced the activity of EGCG as a 
promising antiviral agent against HSV-1 infection (Oliveira et al. 2013) and lipophilic EGCG effective treatment against HSV as a 
topical application (Zhao et al. 2012). Also, dimmers of EGCG inactivate HSV-1 and HSV-2 more successfully between pH 4.0 and 6.6 
than the monomer of EGCG. This mechanism may be more effective in reducing the spread of HSV in vivo because predilection sites of 
HSV are skin and vagina where pH is considerably low (Isaacs et al. 2011). 
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Feline Calicivirus (FVS) A Surrogate of Norovirus and Other Virus Infections  
 
Norovirus fits into the family of Caliciviridae, which is the basis for the outbreak of gastroenteritis in human and is considered 
a major cause of food-borne pathogens worldwide and associated with severe childhood diarrhea (Payne et al. 2013). The causes is 
typically mild self-limiting and associated with symptoms lasting 24-48 h. Chronic persistent infections can be fatal in children (Payne et 
al. 2013). Twenty-one million cases occur annually with 800 deaths (Hall et al. 2012). Hydrolysable tannin of green tea elicits the 
reduction of four or more log10 in norovirus load (Ueda et al. 2013). Catechin also shows activity against the FCV, which is the surrogate 
of norovirus. Among catechins tested, EGCG showed the most effective antiviral activity with a half-effective concentration (EC50) of 12 
mg/ml with relatively low cytotoxicity with a half-cytotoxic concentration (CC50) of 320 mg/ml (Oh et al. 2013). Catechin ointments 
prepared from GTE have been shown to inhibit the human papillomavirus (HPV) at concentrations from 160 to 360 µM (Tyring, 2012). 
Human T-cell leukemia caused by human T-cell lymphotropic virus type-1 (HTLV-1) may also be treated with EGCG as well as green 
tea extract as a whole (Araya et al. 2011). Green tea is reported to reduce the HTLV-1 provirus in peripheral blood lymphocytes in the 
HTLV-1 carrier (Sonoda et al. 2004), that downregulates the protein expression of an anti-apoptotic member (Harakeh et al. 2008). 
Recent studies have shown that (-)-epigallocatechin gallate (Figure 1) is a major compound to norovirus (Ryu et al. 2015).  
 
 
 
 
Figure 1 
 
Chikungunya Virus Infection 
 
CHIKV is a mosquito-transmitted alphavirus that causes chikungunya fever in humans. The disease is characterized by a 
sudden onset of fever, headache, malaise, arthralgia or arthritis, myalgia, and lower back pain (Suhrbier et al. 2012; Weaver et al. 2012). 
After the acute phase, polyarthritis can be recurrent and may persist for several years after infection, which is a serious public health 
problem. Aedes albopictus, the mosquito, inhabits temperate regions, including Europe and USA (Tsetsarkin et al. 2007), reported in 
Caribbean where they have been introduced (Bajak, 2014; Kuehn, 2014). There is no vaccine or medicine for this disease. Recent studies 
show that the main components of green tea, catechin and EGCG inhibit virus CHIKV infection (Weber et al. 2015). 
 
 
 
Figure 2. 
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Figure 3 
 
 
Figure 4 
 
 
 
 
 
 
Figure 5 
 
Conclusions and Future Prospects  
 
The development of resistant mutants of viruses limits the use of presently accepted drugs and constantly challenges us to 
develop new drugs and formulations for the control and proliferation of viruses. Natural products and derivatives afford an outstanding 
resource for developing new and effective antiviral compounds to treat a variety of viral diseases, particularly in developing countries. 
The medicinal effects of polyphenolic compounds present in green tea have a history dating back approximately 5000 years. Green tea 
provides a dietary source of biologically active compounds that have shown efficacy in prevention of a number of viral diseases in 
humans and animals. These polyphenolic compounds, particularly catechins inhibit viral infections by inhibiting viral entry, reverse 
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transcriptase of HIV, HCV protease and several other associated enzymes. However, most of these findings regarding antiviral effects 
have been based on primarily in vitro chemical assays. There is a need to elucidate further and develop animal model systems to 
articulate precisely the pathways and mechanisms involved in the antiviral effects of green tea and its ingredients, and its precise 
therapeutic effects in vivo. Recently, EGCG were investigated using the rotavirus as a model of enteric virus system in cell culture 
without cytotoxicity showing not adverse effects at the concentration assayed (Lipson et al. 2015). 
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